This announcement is a separate document:
立信会计师事务所关于国邦医药2023年度非经营性资金占用及其他关联资金往来情况的专项审计报告
Lixin Certified Public Accountants Limited\'s special audit report on Guobang Pharmaceutical\'s 2023 non-operating capital occupation and other related capital transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.